🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

10 results for “Laboratoire” Clear

  1. ACTISOUFRE, solution pour pulvérisation nasale/buccale en flacon pressurisé, Actisoufre Placebo

    Laboratoire HRA Pharma

    rhinosinusitis not requiring antibiotic therapy, rhinopharyngitis not requiring antibiotic therapy, Acute rhinitis not requiring antibiotic therapy

    phase 3 small molecule active

    1 trial

  2. Placebo

    Laboratoire HRA Pharma

    Leber congenital amaurosis (LCA)

    phase 3 small molecule active

    1 trial

  3. Pravafenix 40 mg/160 mg hard capsules

    Laboratoire HRA Pharma

    Dyslipidaemia

    phase 3 small molecule active

    1 trial

  4. Placebo of NAL, NACYSTELYN

    Laboratoire HRA Pharma

    Obstructive Sleep Apnea

    phase 2 small molecule active

    1 trial

  5. Preservative-free, ophthalmic solution

    Laboratoire HRA Pharma

    Paediatric myopia

    phase 2 small molecule active

    1 trial

  6. Verkazia 1 mg/mL eye drops, emulsion

    Laboratoire HRA Pharma

    Vernal Keratoconjunctivitis (VKC)

    phase 2 small molecule active

    1 trial

  7. sham group will undergo a procedure that will closely mimic the active injection but with no penetration of the globe.

    Laboratoire HRA Pharma

    Retinitis Pigmentosa

    phase 2 small molecule active

    1 trial

  8. sham group will undergo a procedure that will closely mimic the active injection but with no penetration of the globe.

    Laboratoire HRA Pharma

    Retinitis Pigmentosa

    phase 2 small molecule active

    1 trial

  9. A single-dose, randomized, two-period, two-sequence, crossover comparative bioavailability study on formulations containing ramipril, amlodipine and indapamide in combination product versus Triatec® 10 mg capsules (Sanofi - Produtos Farmacêuticos, Lda., Portugal), containing ramipril, Norvasc® 10 mg, tablets (Upjohn EESV, the Netherlands), containing amlodipine and Natrilix® 2.5 mg film-coated tablets (Les Laboratoires Servier, France), containing indapamide co-administered together as reference in healthy

    Pharma Mar S.A.

    hypertension

    phase 1 other active

    1 trial

  10. D-CURE 25000 UI gélules., Placebo of vitamin D

    Laboratoire HRA Pharma

    Periodontitis

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources